Loading
DX
DNA X, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest was filed 18 Sept 2023.
DNA X, Inc.: what insiders have been doing
This page follows insider dealings at DNA X, Inc. as filed with SEC (Form 4) based in San Mateo, United States. The group dates from 1999. 2 insiders have disclosed 2 filings since 18 October 2025.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Compared with its exchange (5,458 companies, median 22 filings), a count of 2 filings is below the norm. Our records for DNA X, Inc. go back to 2021, with 5 purchases and 17 sales on the open market in total.
Insider buying of DNA X, Inc. has been absent for the past year.
Other companies in the same market with recent insider buying flagged by our signals: GameStop Corp. and Heico Corp. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
67
Thresholds
n/a
Buy Volume
€5M
5 ops. · all time
Sell Volume
€869,449
17 ops. · all time
Who traded when
BuySaleCharles Becher1 sale
Clayton Crolius1 sale
Jack Steenstra1 sale
James S. Cassano1 sale
Jeffrey Wang1 sale
Laurence W. Lytton1 sale
+1 other insider
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Last declaration on 10 February 2026
Declarations67 total
35,000 shares0Common StockSEC:0001493152-26-006055:0
50,000 shares0Common StockSEC:0001493152-26-006053:0
466,402 shares@ US$1.50100.0% of flowCommon StockSEC:0000935836-25-000440:0
27,818 shares@ US$1.45100.0% of flowCommon StockSEC:0001641172-25-006118:0
11,634 shares@ US$1.4521.1% of flowCommon StockSEC:0001641172-25-006117:0
23,381 shares@ US$1.4584.5% of flowCommon StockSEC:0001641172-25-006116:0
31,326 shares@ US$1.4545.8% of flowCommon StockSEC:0001641172-25-006115:0
23,381 shares@ US$1.4584.6% of flowCommon StockSEC:0001641172-25-006119:0
4,478 shares@ US$1.4551.2% of flowCommon StockSEC:0001641172-25-006120:0
46,728 shares0Common StockSEC:0001641172-25-002391:0
46,728 shares0Common StockSEC:0001641172-25-002381:0
46,728 shares0Common StockSEC:0001641172-25-002389:0
63,604 shares0Common StockSEC:0001493152-25-005766:0
33,922 shares0Common StockSEC:0001493152-25-005765:0
70,671 shares0Common StockSEC:0001493152-25-005764:0
14,124 shares0Common StockSEC:0001493152-24-045937:0
1,623 shares@ US$3.6715.4% of flowCommon StockSEC:0001493152-24-028778:0
1,623 shares@ US$3.6815.5% of flowCommon StockSEC:0001493152-24-028777:0
1,623 shares@ US$3.6748.8% of flowCommon StockSEC:0001493152-24-028776:0
78,947 shares0Common StockSEC:0001493152-24-024962:0
78,947 shares0Common StockSEC:0001493152-24-024961:0
78,947 shares0Common StockSEC:0001493152-24-024964:0
78,947 shares0Common StockSEC:0001493152-24-024963:0
66,675 shares0Common StockSEC:0001493152-24-001982:0
125,000 shares@ US$0.41954.2% of flowCommon StockSEC:0001493152-23-046419:0
25 of 67 declarations
About DNA X, Inc.
DNA X, Inc. is a company listed on the XNAS market. It specializes in developing innovative solutions in the biotechnology sector.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations
